->

Tag: Novartis Pharmaceuticals Corporation

Home / Yakagadzwa Gore

, , , , , ,

Tisagenlecleucel inotenderwa neFDA yekudzokorora kana refractory follicular lymphoma

Chikumi 2022: Mushure memitsara miviri kana kupfuura yesystemic therapy, FDA yakapa tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yakakurumidza kubvumidza kuvarwere vakura vane relapsed kana refractory follicular lymphoma (FL) T.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa